NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Goebel A, Bisla J, Carganillo R, et al. A randomised placebo-controlled Phase III multicentre trial: low-dose intravenous immunoglobulin treatment for long-standing complex regional pain syndrome (LIPS trial). Southampton (UK): NIHR Journals Library; 2017 Nov. (Efficacy and Mechanism Evaluation, No. 4.5.)
A randomised placebo-controlled Phase III multicentre trial: low-dose intravenous immunoglobulin treatment for long-standing complex regional pain syndrome (LIPS trial).
Show detailsGeneral definition of the syndrome
Complex regional pain syndrome describes an array of painful conditions that are characterised by a continuing (spontaneous and/or evoked) regional pain that is seemingly disproportionate in time or degree to the usual course of any known trauma or other lesion. The pain is regional (not in a specific nerve territory or dermatome) and usually has a distal predominance of abnormal sensory, motor, sudomotor, vasomotor, and/or trophic findings. The syndrome shows variable progression over time.
To make the clinical diagnosis, the following criteria must be met:
- Continuing pain, which is disproportionate to any inciting event.
- Must report at least one symptom in all four of the following categories:
- sensory – reports of hyperaesthesia and/or allodynia
- vasomotor – reports of temperature asymmetry and/or skin colour changes and/or skin colour asymmetry
- sudomotor/oedema – reports of oedema and/or sweating changes and/or sweating asymmetry
- motor/trophic – reports of decreased range of motion and/or motor dysfunction (weakness, tremor, dystonia) and/or trophic changes (hair, nail, skin).
- Must display at least one sign at time of evaluation in two or more of the following categories:
- sensory – evidence of hyperalgesia (to pinprick) and/or allodynia (to light touch and/or temperature sensation and/or deep somatic pressure and/or joint movement)
- vasomotor – evidence of temperature asymmetry (> 1 °C) and/or skin colour changes and/or asymmetry
- sudomotor/oedema – evidence of oedema and/or sweating changes and/or sweating asymmetry
- motor/trophic – evidence of decreased range of motion and/or motor dysfunction (weakness, tremor, dystonia) and/or trophic changes (hair, nail, skin)
- There is no other diagnosis that better explains the signs and symptoms.
- Research diagnostic criteria (the ‘Budapest Criteria’) for complex regional pain...Research diagnostic criteria (the ‘Budapest Criteria’) for complex regional pain syndrome - A randomised placebo-controlled Phase III multicentre trial: low-dose intravenous immunoglobulin treatment for long-standing complex regional pain syndrome (LIPS trial)
Your browsing activity is empty.
Activity recording is turned off.
See more...